Kevin K. Gordon
Kevin K. Gordon joined the Veracyte board in December 2016. Mr. Gordon served as executive vice president and COO of Quintiles Transnational Holdings Inc., a leading global bio-pharmaceutical services provider, from October 2015 until its merger with IMS Health in October 2016. He served as the company’s executive vice president and chief financial officer from July 2010 to December 2015. The Fortune 500 company recorded revenue of $4.3 billion in 2015 and was named to Fortune’s list of the “World’s Most Admired Companies.”
Prior to that, Mr. Gordon spent 13 years in senior leadership positions at Teleflex Incorporated (NYSE: TFX), a diversified global company with over $2 billion in annual revenue, where he served as executive vice president and CFO from March 2007 to January 2010. He previously held senior management positions at KPMG. Mr. Gordon served as chairman of the board of SSI Surgical Services, Inc. He holds a B.S. in Accounting from the University of Connecticut.